Rx-Infinity Therapeutics Private Limited
About Rx-Infinity Therapeutics Private Limited
Data last updated:
Rx-Infinity Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 31 May 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC173621.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ramadevi Amaram and Manikanth Reddy Yarala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.53 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.53 Lakh (net margin 12.9%) and EBITDA of ₹2.53 Lakh (EBITDA margin 12.9%).
Company details
Contact details
Rx-Infinity Therapeutics Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH.No.Mig – 1139, Mayuri Nagar, Hyderabad, Telangana, India – 500049
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rx-Infinity Therapeutics is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Rx-Infinity Therapeutics Private Limited, buy the company report.
Financials of Rx-Infinity Therapeutics Private Limited
FY 2025 filings availableRx-Infinity Therapeutics Private Limited reported revenue of ₹19.53 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year. EBITDA fell 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹2.53 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹2.53 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 12.9% | |
| Net Profit Margin | 12.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rx-Infinity Therapeutics Private Limited, buy the company report.
Board of directors of Rx-Infinity Therapeutics Private Limited
Rx-Infinity Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramadevi Amaram Also directs: Eswar Bio Briquette India Private Limited | Director | 31 May 2023 | 3 Years 5 Months | Current |
| Manikanth Reddy Yarala Also directs: Tervis Therapeutics LLP, Energon Labs Private Limited | Director | 31 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Rx-Infinity Therapeutics Private Limited is compared with the 3 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DND Consultants Private Limited | ₹19.53 Lakh (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Rx-Infinity Therapeutics Private Limitedthis company | ₹19.53 Lakh (FY 2025) | ₹2.53 Lakh | 12.9% | -8.0% | Hyderabad, Telangana, India | |
| MVJ Associates Private Limited | ₹19.53 Lakh (FY 2024) | 4.0% | Pune, Maharashtra, India | |||
| Toparch Digital Private Limited | ₹19.53 Lakh (FY 2025) | 47.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Rx-Infinity Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rx-Infinity Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rx-Infinity Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rx-Infinity Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rx-Infinity Therapeutics Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Manikanth Reddy Yarala was appointed as Director on 31 May 2023.
Frequently asked questions
Rx-Infinity Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 31 May 2023 (3+ years old) and is registered under CIN U21001TS2023PTC173621.
Rx-Infinity Therapeutics has 2 current directors:
- Ramadevi Amaram - Director
- Manikanth Reddy Yarala - Director
The latest financial statements of Rx-Infinity Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Rx-Infinity Therapeutics is U21001TS2023PTC173621. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rx-Infinity Therapeutics was incorporated on 31 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rx-Infinity Therapeutics by revenue are DND Consultants Private Limited, MVJ Associates Private Limited, Toparch Digital Private Limited, all in the same principal business activity (other professional, scientific and technical activities).
Manikanth Reddy Yarala was appointed as Director on 31 May 2023. Ramadevi Amaram was appointed as Director on 31 May 2023.
The registered office of Rx-Infinity Therapeutics is at H.No.Mig – 1139, Mayuri Nagar, Hyderabad, Telangana, India – 500049.
Rx-Infinity Therapeutics operates in the paper industry, in the paper and paper products segment.
Rx-Infinity Therapeutics can be reached at its registered office: H.No.Mig – 1139, Mayuri Nagar, Hyderabad, Telangana, India – 500049.
Rx-Infinity Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
